| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/06/2011 | US20110003307 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 01/06/2011 | US20110003010 Phosphoric Acid Esters Containing Phosphorus Atoms Bridged By Diol Units |
| 01/06/2011 | US20110003001 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002984 Formulations comprising exine shells |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002971 Ceria for use as an antimicrobial barrier and disinfectant in a wound dressing |
| 01/06/2011 | US20110002970 Process for the preparation of nano zinc oxide particles |
| 01/06/2011 | US20110002962 Immunogenic PcpA Polypeptides and Uses Thereof |
| 01/06/2011 | US20110002960 Influenza hemagglutinin and neuraminidase variants |
| 01/06/2011 | US20110002959 Vaccine Production For Pathogenic Bird Viral Diseases |
| 01/06/2011 | US20110002958 Alphavirus Vectors for Respiratory Pathogen Vaccines |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 01/06/2011 | US20110002951 Modified Leukotoxin Gene and Protein |
| 01/06/2011 | US20110002943 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 01/06/2011 | US20110002937 Method of making hybrid cells that express useful antibodies |
| 01/06/2011 | US20110002933 Dr4 antibodies and uses thereof |
| 01/06/2011 | US20110002932 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
| 01/06/2011 | US20110002926 Hepatitis c virus antibodies |
| 01/06/2011 | US20110002913 Use of interleukin-4 antagonists and compositions thereof |
| 01/06/2011 | US20110002909 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 01/06/2011 | US20110002891 Probiotic compositions and process thereof |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002886 Tetrahydrofuro [3,4-d] dioxolane compounds for use in the treatment of viral infections and cancer |
| 01/06/2011 | US20110002884 Therapeutic compounds |
| 01/06/2011 | US20110002877 PTEN Inhibitors Treat Neutropenia-Associated Pneumonia |
| 01/06/2011 | US20110002861 Composition comprising pure aloe and its use as a cosmetic base |
| 01/06/2011 | US20110002859 Chewing gum containing eucalyptus extract |
| 01/06/2011 | US20110002857 Oleaginous pharmaceutical and cosmetic foam |
| 01/06/2011 | US20110000480 Administration of interferon for prophylaxis against or treatment of pathogenic infection |
| 01/06/2011 | CA2767183A1 Covalent inhibition of bacterial quorum sensing |
| 01/06/2011 | CA2766899A1 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | CA2766805A1 Hyr1 as a target for active and passive immunization against candida |
| 01/06/2011 | CA2765852A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | CA2763194A1 Treatment and prevention of dengue virus infections |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270174A1 Combination neisserial compositions |
| 01/05/2011 | EP2270173A1 Combination neisserial compositions |
| 01/05/2011 | EP2270172A1 Combination neisserial compositions |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270162A2 Conserved HBV and HCV sequences useful for gene silencing |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270044A1 Liquid immunoglobulin G (lgG) product |
| 01/05/2011 | EP2270032A2 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeenis |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269992A1 Bicyclic pyrimidinones for the treatment of viral infections |
| 01/05/2011 | EP2269991A2 Substituted tetracycline compounds |
| 01/05/2011 | EP2269985A2 Substituted tetracycline compounds |
| 01/05/2011 | EP2269978A2 Substituted tetracycline compounds |
| 01/05/2011 | EP2269694A2 Antituberculous composition comprising oxazole compounds |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269643A2 Hcv vaccine compositions |
| 01/05/2011 | EP2269642A2 Hcv vaccine compositions |
| 01/05/2011 | EP2269641A2 Hcv vaccine compositions |
| 01/05/2011 | EP2269640A2 Hcv vaccine compositions |
| 01/05/2011 | EP2269639A2 Influenza vaccine formulations for intradermal delivery |
| 01/05/2011 | EP2269637A1 Influenza Vaccine |
| 01/05/2011 | EP2269635A1 Enterococcus antigens and vaccines |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2269627A1 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same |
| 01/05/2011 | EP2269611A2 EP2 and EP4 agonists as agents for the treatment of influenza A viral infection |
| 01/05/2011 | EP2269602A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 01/05/2011 | EP2269591A2 Improved pharmaceutical formulations |
| 01/05/2011 | EP2268659A2 Mutant forms of chlamydia htra |
| 01/05/2011 | EP2268648A1 Crystalline (6r,7r)-7-{2-(5-amino-ý1,2,4¨thiadiazol-3-yl)-2-ý(z)-trityloxyimino¨-acetylamino}-3-ý(r)-1'-tert-butoxycarbonyl-2-oxo-ý1,3'¨bipyrrolidinyl-(3e)-ylidenemethyl¨-8-oxo-5-thia-1-aza-bicycloý4.2.0¨oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use |
| 01/05/2011 | EP2268643A1 Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors |
| 01/05/2011 | EP2268642A1 1' -substituted carba-nucleoside analogs for antiviral treatment |
| 01/05/2011 | EP2268294A1 Propolis extract |
| 01/05/2011 | EP2268289A1 Anti-infective agents and uses thereof |
| 01/05/2011 | EP2268288A2 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| 01/05/2011 | EP2268272A2 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| 01/05/2011 | EP2121696B1 Compounds for the treatment of hepatitis c |
| 01/05/2011 | EP1912999B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/05/2011 | EP1908467B1 Agent for treating herpesvirus-derived pain |
| 01/05/2011 | EP1747023B1 Methods and compositions for reducing hcv viral genome amounts in a target cell |
| 01/05/2011 | EP1663315B1 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2011 | EP1453471B1 Expression vectors encoding epitopes of antigens and methods for their design |
| 01/05/2011 | EP1334197B1 Yeast derived vaccine against ipnv |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | CN1985922B Medicine composition for treating common cold and its preparing method |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939030A Use of alginate oligomers in combating biofilms |
| 01/05/2011 | CN101939027A Lipopeptides for delivery of nucleic acids |
| 01/05/2011 | CN101939026A Antibacterial combination therapy |
| 01/05/2011 | CN101939015A Novel hydroxy radical generation method, and anti-viral material utilizing hydroxy radical generated by the method |
| 01/05/2011 | CN101939012A Macrolides for treating diseases mediated through PDE inhibition |
| 01/05/2011 | CN101938999A Antimicrobial compositions comprising fatty acids and milk proteins |
| 01/05/2011 | CN101935640A Bacterial colony induction signal degrading enzyme and coding gene and application thereof |
| 01/05/2011 | CN101935637A Recombinant low-virulent vaccine strain of chicken infectious bursal disease viruses (IBDV) and application thereof |
| 01/05/2011 | CN101935624A Bacillus subtillis and method for preparing raw powder of each gram of bacillus subtillis with 1 trillion live germs |
| 01/05/2011 | CN101935341A Polypeptide with activity of inhibiting beta-lactamase and preparation method and application thereof |
| 01/05/2011 | CN101935335A Crowe saponins as well as preparation method and application thereof in resisting highly pathogenic H5N1 influenza virus |
| 01/05/2011 | CN101935333A Phosphonate analogs of HIV inhibitor compounds |